(Image via YouTube)
A Johns Hopkins spinout has FDA approval and a Series A in hand, and is set to step up sales of its system to improve biopsy imaging.
Clear Guide Medical closed on $1.5 million in new funding, and could double that number with add-on investments in the near future. The round was led by Georgia-based Wildermuth Advisory.
Clear Guide Medical received its CE Mark on the SCENERGY today! A good way to end the week. We also had a… https://t.co/dDBhghPdQ7
— CLEAR GUIDE MEDICAL (@ClearGuide) April 15, 2016
The new money follows FDA approval in February for the company’s imaging product, called SCENERGY. Sold as an accessory to ultrasound machines, it includes a “SuperPROBE” that links an ultrasound’s existing probe with the Clear Guide system. It helps specialists conducting biopsies to work with CT and ultrasound images at the same time. The system also has an automated registration process designed to reduce time.
Formed by a group of Johns Hopkins researchers in 2010, Clear Guide Medical currently works with several hospitals. The startup is looking to expand sales in the U.S. and Europe.-30-
Meet the Aerium: An algae air purifier created by IMET PhD candidates
5 questions with Jason Becker: Leading product development through an equity lens at Allovue
These 9 companies are entering Conscious Venture Lab’s accelerator
Why two eminent Baltimore higher-ed institutions collaborated to create this unique dual degree program
Medical device company Sonavex receives $3M grant from NIH
Johns Hopkins is launching an accelerator for student startups
How to run your own team retreat: The prep
What Asymmetrik is doing to help lead healthcare’s digital transformation
Sign-up for daily news updates from Technical.ly Baltimore